May 5, 2024

You May Have Misconceptions About E-Cigarettes – Many Doctors Do Too

The Food and Drug Administration has not authorized e-cigarettes as a cessation gadget, numerous individuals ask their doctors about using them as an option to tobacco cigarettes or as a method to help them stop smoking. The research study found that physicians were substantially more most likely to suggest e-cigarettes for the heavy smoker while recommending FDA-approved medications, like nicotine gum or lozenges, for the light smoker. Nearly 70 percent of the doctors reported that clients have asked them about e-cigarettes, and one-third said they were asked in the previous 30 days.

The majority of physicians want more evidence on safety and efficiency before suggesting them as an alternative to cigarette smoking.
Many physicians incorrectly believe all tobacco products are similarly harmful and hence are less likely to advise e-cigarettes for individuals seeking to stop smoking or those being dealt with for a tobacco-caused disease, according to a Rutgers research study.

About 480,000 people die each year in the United States from smoking cigarettes tobacco. Although the Food and Drug Administration has actually not approved e-cigarettes as a cessation gadget, lots of people ask their physicians about using them as an alternative to tobacco cigarettes or as a way to help them stop smoking. E-cigarettes utilize a heated liquid containing nicotine.
” As the evidence grows showing e-cigarettes as potentially effective for smoking cigarettes cessation, they may play a critical role in reducing use of cigarettes and consequently tobacco-caused illness,” stated research study author Michael Steinberg, medical director of the Rutgers Tobacco Dependence Program at the Center for Tobacco Studies and division chief in the Department of Medicine at the Rutgers Robert Wood Johnson Medical School. “Its crucial to comprehend doctors perspectives on e-cigarettes as a means for harm reduction.”
The research study, published in JAMA Network Open, asked 2,058 U.S. doctors in 2018 and once again in 2019 about their communication with clients about e-cigarettes. The scientists asked how they would encourage 2 different patients who wished to quit smoking cigarettes: a young female who is a lighter cigarette smoker and had not yet tried to quit and an older male who smoked heavily and had actually attempted to give up sometimes using various techniques.
The study found that physicians were substantially most likely to recommend e-cigarettes for the heavy cigarette smoker while advising FDA-approved medications, like nicotine gum or lozenges, for the light cigarette smoker. Nearly 70 percent of the physicians reported that patients have actually asked about e-cigarettes, and one-third stated they were asked in the past 30 days. More than 60 percent of the doctors incorrectly thought that all tobacco items are equally damaging.
” These findings show it is vital to attend to physicians misperceptions and inform them on e-cigarettes efficacy, particularly correcting their misperceptions that all tobacco items are similarly harmful, as opposed to the fact that combusted tobacco is without a doubt the most unsafe,” said lead author Cristine Delnevo, director of the Rutgers Center for Tobacco Studies and professor of Health Behavior, Society and Policy in the Rutgers School of Public Health.
The study also discovered that doctors, cardiologists and pulmonologists who used the U.S. Public Health Service Clinical Practice Guidelines for treating tobacco use and dependence were more likely to advise e-cigarettes to clients as were those who backed a harm-reduction viewpoint and had themselves smoked cigarettes. Physicians were also more likely to advise e-cigarettes, nevertheless, if a patient inquired about them initially.
Recommendation: “Communication Between United States Physicians and Patients Regarding Electronic Cigarette Use” 15 April 2022, JAMA Network Open.DOI: 10.1001/ jamanetworkopen.2022.6692.
Other Rutgers authors in the study consisted of Michelle Jeong, Arjun Teotia, Michelle M. Bover Manderski, Binu Singh, Mary Hrywna and Olivia A. Wackowski.